CA19–9 and CEA are widely accepted tumor serum biomarkers for CRC and elevated preoperative CA19–9 and CEA level have been considered as an independent prognostic factor for DFS (Disease Free Survival) in CRC patients [32]. This evidence concerns the gene CEACAM5 and colorectal carcinoma.